Akcea Therapeutics Inc (AKCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58,367 | 110,366 | 75,445 | N/A | N/A |
| Marketable Securities | 201,763 | 175,765 | 43,223 | N/A | N/A |
| Receivables | 5,413 | 500 | N/A | N/A | N/A |
| Other current assets | 1,302 | 1,249 | 3,939 | 0 | 0 |
| TOTAL | $266,845 | $287,880 | $122,607 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 77 | 104 | 114 | N/A | N/A |
| Intangibles | 1,221 | 1,251 | 1,281 | 0 | 0 |
| Other Non-Current Assets | 661 | 114 | 102 | 0 | 0 |
| TOTAL | $1,959 | $1,469 | $1,497 | $N/A | $N/A |
| Total Assets | $268,804 | $289,349 | $124,104 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 16,746 | 11,513 | 11,387 | 0 | 0 |
| Accrued Expenses | 11,653 | 5,759 | 3,465 | N/A | N/A |
| Other current liabilities | 1,875 | 2,142 | N/A | N/A | N/A |
| TOTAL | $88,466 | $73,457 | $69,047 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 107,507 | N/A | N/A |
| Deferred Revenues | 58,192 | 54,043 | 54,195 | N/A | N/A |
| TOTAL | $12,513 | $18,049 | $138,040 | $N/A | $N/A |
| Total Liabilities | $100,979 | $91,506 | $207,087 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 66,631 | 66,542 | 66,542 | N/A | N/A |
| Common Shares | 67 | 67 | N/A | N/A | N/A |
| Retained earnings | -296,221 | -261,052 | -246,958 | N/A | N/A |
| Other shareholders' equity | -451 | -222 | 99,916 | 0 | 0 |
| TOTAL | $167,825 | $197,843 | $-82,983 | $N/A | $N/A |
| Total Liabilities And Equity | $268,804 | $289,349 | $124,104 | $0 | $0 |